Hospital advertises for ‘corridor care doctor’ as A&E crisis deepens - Top doctor warns the need for the ad was a ...

TNF Pharma begins phase 2b clinical trial to evaluate oral TNF-alpha inhibitor drug candidate isomyosamine: Baltimore Thursday, February 27, 2025, 18:00 Hrs [IST] TNF Pharmaceutic ...